GZ3ZZZZICD-10-PCS GZ3ZZZZ is a specific/billable code that can be used to indicate a procedure.
01 (Long term (current) use of anticoagulants) if the patient is taking anticoagulants, Z51. 81 (Encounter for therapeutic drug level monitoring) if the agency is monitoring PT/INRs, and Z95.May 18, 2018
Z76. 89 is a billable diagnosis code used to specify a medical diagnosis of persons encountering health services in other specified circumstances.
The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes. Because Plaquenil does not have its own specific category, clinicians should use Z79. 899—Other Long Term (Current) Drug Therapy.Aug 15, 2017
11: Encounter for antineoplastic chemotherapy.
89 as the primary diagnosis and the specific drug dependence diagnosis as the secondary diagnosis. For the monitoring of patients on methadone maintenance and chronic pain patients with opioid dependence use diagnosis code Z79. 891, suspected of abusing other illicit drugs, use diagnosis code Z79. 899.
9: Person encountering health services in unspecified circumstances.
Other long term (current) drug therapy Z79. 899 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10 code Z76. 0 for Encounter for issue of repeat prescription is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10 | Other fatigue (R53. 83)
CPT codes, descriptions and other data only are copyright 2020 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
Language quoted from Centers for Medicare and Medicaid Services (CMS), National Coverage Determinations (NCDs) and coverage provisions in interpretive manuals is italicized throughout the policy.
The Medicare Administrative Contractor has determined in review of submitted claims that there is inappropriate use of CPT codes 96401-96549 for chemotherapy and other highly complex drug or highly complex biologic agent administration.
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code Z76.89:
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code (s). The following references for the code Z76.89 are found in the index:
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
Z76.89 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG).
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code Z76.89 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.